| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |